Literature DB >> 9479002

Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein.

Y Revilla1, M Callejo, J M Rodríguez, E Culebras, M L Nogal, M L Salas, E Viñuela, M Fresno.   

Abstract

Certain viruses have evolved mechanisms to counteract innate immunity, a host response in which nuclear factor kappaB (NF-kappaB) transcription factors play a central role. African swine fever virus encodes a protein of 28.2 kDa containing ankyrin repeats similar to those of cellular IkappaB proteins, which are inhibitors of NF-kappaB. Transfection of the African swine fever virus IkappaB gene inhibited tumor necrosis factor- or phorbol ester-induced activation of kappaB- but not AP-1-driven reporter genes. Moreover, African swine fever virus IkappaB co-immunoprecipitated with p65 NF-kappaB, and the purified recombinant protein prevented the binding of p65-p50 NF-kappaB proteins to their target sequences in the DNA. NF-kappaB activation induced by tumor necrosis factor, as detected by mobility shift assays or by transfection of kappaB-driven reporter genes, is impaired in African swine fever virus-infected cells. These results indicate that the African swine fever virus IkappaB gene homologue interferes with NF-kappaB activation, likely representing a new mechanism to evade the immune response during viral infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479002     DOI: 10.1074/jbc.273.9.5405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT.

Authors:  J E Miskin; C C Abrams; L K Dixon
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 4.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 5.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

6.  Inhibitor kappaB-like proteins from a polydnavirus inhibit NF-kappaB activation and suppress the insect immune response.

Authors:  Honglada Thoetkiattikul; Markus H Beck; Michael R Strand
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

7.  Transcription program of red sea bream iridovirus as revealed by DNA microarrays.

Authors:  Dang Thi Lua; Motoshige Yasuike; Ikuo Hirono; Takashi Aoki
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.

Authors:  Soo-Ho Choi; Kyu-Jin Park; Byung-Yoon Ahn; Guhung Jung; Michael M C Lai; Soon B Hwang
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  The African swine fever virus protein j4R binds to the alpha chain of nascent polypeptide-associated complex.

Authors:  Lynnette C Goatley; Steve R F Twigg; James E Miskin; Paul Monaghan; René St-Arnaud; Geoffrey L Smith; Linda K Dixon
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Regulation of host translational machinery by African swine fever virus.

Authors:  Alfredo Castelló; Ana Quintas; Elena G Sánchez; Prado Sabina; Marisa Nogal; Luis Carrasco; Yolanda Revilla
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.